JTI Launches Heated Tobacco Product "Ploom" in Philippines

Nov.12.2024

JTI introduces new heated tobacco product "Ploom" in the Philippines, aiming to expand product portfolio and market influence.

Japan Tobacco International (JTI) has announced the launch of their heated tobacco product "Ploom" in the Philippines to expand their product portfolio in the country, according to Philstar's report on November 12.

JTI Launches Heated Tobacco Product — Japan Tobacco International launched the heated tobacco product "Ploom" in the Philippines | Image Source: JTI Official Website

"The year 2024 has been a landmark one for JTI in the market, so it is a very exciting time for us. Having been awarded Top Employer for the third year in a row, we are also the fastest growing tobacco company in the Philippines. With the introduction of Ploom, it is another remarkable milestone as we are proud to be the first in Asia, outside of Japan, to launch the brand – a sign of our commitment to continue building on our expanding market presence,” JTI Philippines general manager John Freda said.

The company added that it aims to build a strong consumer base for Ploom in the Philippines and further drive the adoption of heated tobacco products.

References:

[1] JTI launches Ploom in Philippines

Also Read:

[1] Japan Tobacco launches 'With 2 Special Edition' HTP device, priced from $26

[2] Japanese Tobacco Corporation Launches New Color for Ploom X Advanced

[3] New Camel Pod Flavors for Ploom X Advanced Released in Japan

[4] JT Launches New Champagne Gold Color for Ploom X ADVANCED

[5] JT Group to Acquire Vector Group Ltd. for $2.4B, US Market Share Up to 8%

[6] JT Launches Special Edition Red Design for Ploom X ADVANCED

[7] JTI to Invest $80 Million in Tobacco Processing Facility in Kazakhstan

#Asia #Market #Philippines #Heated tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Product | Magnetic-attach design + mini display: FASTA’s new product goes on sale in the U.S., priced around $16

FASTA’s 40K Kit hits U.S. retailers: magnetic prefilled pods + reusable battery, mini display, two power levels; rated 20 mL/40,000 puffs/50 mg; some listings at $15.99.

Oct.15 by 2FIRSTS.ai

Illegal Vape Sellers in the Netherlands Could Be Fined Up to €4,040

The outgoing Dutch government plans to raise fines for illegal sales of vapes and cigarettes, with first-time offenders facing a €2,040 penalty. The new fines, up to €4,040 for large companies, are expected to take effect on July 1, 2026, pending parliamentary approval.

Nov.10 by 2FIRSTS.ai

Kyrgyzstan considers six-month ban on e-cigarette and e-cigarettee-liquid imports

According to Kyrgyz media, the Ministry of Economy and Commerce has launched a public discussion on a draft decree proposing a six-month ban on the import of e-cigarettes and nicotine-containing liquids. The measure, based on Article 15-1 of the Law “On Protecting Citizens’ Health from the Consequences of Tobacco and Nicotine Use,” aims to safeguard public health and prevent youth nicotine addiction.